Modern Vampirism: “Young Blood” Transfusions
Blood from young mice has rejuvenating effects on old mice, but it’s too early to translate these results into treatments for humans.
Don’t drink and science: why a study on the cognitive effects of wine and cheese is sheer stupidity
A study claiming that daily consumption of cheese and wine may improve long-term cognition seems more like a bad joke than reliable science.
#266 – AMA #50: Genetics: how they impact disease risk, what you can do about it, testing, and more
“With how much uncertainty there is in genetic testing, I just think everybody needs to be thoughtful about it before they do it.” —Peter Attia
Adding context to the Alzheimer’s disease research fraud charges
This past July, a news article published in Science sent shockwaves through the scientific community when it reported that one of the most influential and frequently-cited publications in Alzheimer’s disease (AD) research was evidently based on fraud.
Studying Studies: Part III – the motivation for observational studies
If randomized-controlled trials are considered the gold standard for establishing reliable knowledge, why do we see so many observational studies in public health?
Alzheimer’s prevention and the most important thing
So ironically, while Marks applies these insights to financial investments, many of the same principles apply to the way we should treat our health.
#52 – Ethan Weiss, M.D.: A masterclass in cardiovascular disease and growth hormone – two topics that are surprising interrelated
“Primary prevention is still very much art and not science and probably will be for our lifetime so we’ll have to get used to that.” —Ethan Weiss
#171 – Steve Austad, Ph.D.: The landscape of longevity science: making sense of caloric restriction, biomarkers of aging, and possible geroprotective molecules
“I never thought [extending the human lifespan] was going to happen because we got better at treating cancer or we got better at preventing heart disease. I always thought it was going to happen because we would develop something … that would fundamentally change the rate of aging. And we haven’t developed that yet. We’ve got a lot of clues and I think we’re getting closer and closer and closer.” —Steve Austad